Michael Myers is Chief Executive Officer of Quoin Pharmaceuticals, Ltd.. Currently has a direct ownership of 602,808 shares of QNRX, which is worth approximately $421,965. The most recent transaction as insider was on Dec 23, 2024, when has been sold 555,556 shares (Ordinary Shares) at a price of $0.45 per share, resulting in proceeds of $250,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 603K
1175.73% 3M change
n/a 12M change
Total Value Held $421,965

Michael Myers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2024
BUY
Open market or private purchase
$250,000 $0.45 p/Share
555,556 Added 47.96%
602,808 Ordinary Shares
Sep 04 2024
BUY
Open market or private purchase
$27,449 $0.74 p/Share
37,094 Added 43.98%
47,252 Ordinary Shares
Sep 03 2024
BUY
Open market or private purchase
$496 $0.62 p/Share
800 Added 7.3%
10,158 Ordinary Shares
MM

Michael Myers

Chief Executive Officer
Ashburn, VA

Track Institutional and Insider Activities on QNRX

Follow Quoin Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QNRX shares.

Notify only if

Insider Trading

Get notified when an Quoin Pharmaceuticals, Ltd. insider buys or sells QNRX shares.

Notify only if

News

Receive news related to Quoin Pharmaceuticals, Ltd.

Track Activities on QNRX